Cargando…

Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes

Two human genetic tubulopathies, Bartter’s (BS) and Gitelman’s (GS) syndromes, have normo/hypotension and absent cardiac remodeling despite their apparent angiotensin system (RAS) activation. This seeming contradiction has led to an extensive investigation of BSGS patients, the result of which is th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sgarabotto, Luca, Ravarotto, Verdiana, Stefanelli, Lucia Federica, Cacciapuoti, Martina, Davis, Paul A., Nalesso, Federico, Calò, Lorenzo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135094/ https://www.ncbi.nlm.nih.gov/pubmed/37107186 http://dx.doi.org/10.3390/antiox12040811

Ejemplares similares

The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes
por: Francini, Francesco, et al.
Publicado: (2021)

Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes
por: Calò, Lorenzo A., et al.
Publicado: (2021)

Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
por: Bertoldi, Giovanni, et al.
Publicado: (2021)

Far di Necessità Virtù, using rare tubulopathies, Gitelman’s and Bartter’s syndromes, to inform the fight against COVID-19
por: Calò, Lorenzo A., et al.
Publicado: (2021)

Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
por: Seyberth, Hannsjörg W., et al.
Publicado: (2011)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
por: Bamgbola, Oluwatoyin Fatai, et al.
Publicado: (2021)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
por: Bamgbola, Oluwatoyin Fatai, et al.
Publicado: (2020)

Bartter and Gitelman syndromes: Questions of class
por: Besouw, Martine T. P., et al.
Publicado: (2019)

Are the Clinical Presentations (Phenotypes) of Gitelman’s and Bartter’s Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their “pH” Enotype?
por: Calò, Lorenzo A, et al.
Publicado: (2020)

Clinical and diagnostic features of Bartter and Gitelman syndromes
por: Walsh, Patrick R, et al.
Publicado: (2018)

Concurrent Gitelman Syndrome-like Tubulopathy and Grave’s Disease
por: Kumar, Rajasekaran Kishore, et al.
Publicado: (2022)

Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
por: Calò, Lorenzo A., et al.
Publicado: (2020)

Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome
por: Palazzo, Viviana, et al.
Publicado: (2022)

Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach
por: Rigato, Matteo, et al.
Publicado: (2022)

The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease
por: Ravarotto, Verdiana, et al.
Publicado: (2021)

Slow Continuous Ultrafiltration in Regional Citrate Anticoagulation Performed with a Standard Fluid Infusion Central Venous Catheter in Intensive Care Unit for Fluid Overload in Acute on Chronic Heart Failure: A Case Report
por: Nalesso, Federico, et al.
Publicado: (2023)

Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study
por: Verploegen, Maartje F A, et al.
Publicado: (2022)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

HNF1B Mutations Are Associated With a Gitelman-like Tubulopathy That Develops During Childhood
por: Adalat, Shazia, et al.
Publicado: (2019)

A novel mutation of CLCNKB in a Korean patient of mixed phenotype of Bartter-Gitelman syndrome
por: Cho, Hee-Won, et al.
Publicado: (2016)

Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians
por: Nuñez-Gonzalez, Laura, et al.
Publicado: (2021)

Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
por: Ravarotto, Verdiana, et al.
Publicado: (2018)

Diuretic loading test and use of Bartter's Normogram in diagnosing a case of Gitelman's syndrome: Relook into pathophysiology
por: Goswami, R. P., et al.
Publicado: (2011)

Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome
por: Tang, Wangna, et al.
Publicado: (2022)

The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing
por: Stevenson, Mark, et al.
Publicado: (2022)

ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements
por: Seccia, Teresa M., et al.
Publicado: (2020)

The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study
por: Bertoldi, Giovanni, et al.
Publicado: (2022)

COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring
por: Nalesso, Federico, et al.
Publicado: (2023)

Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene
por: Al-Shibli, Amar, et al.
Publicado: (2014)

Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
por: Ravarotto, Verdiana, et al.
Publicado: (2018)

A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19
por: Nalesso, Federico, et al.
Publicado: (2020)

Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients
por: Calò, Lorenzo A., et al.
Publicado: (2020)

Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes
por: Dong, Bingzi, et al.
Publicado: (2020)

Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation
por: Stefanelli, Lucia Federica, et al.
Publicado: (2023)

Amyloid proximal tubulopathy: a novel form of light chain proximal tubulopathy
por: Larsen, Christopher P., et al.
Publicado: (2012)

Redefying the therapeutic strategies against cardiorenal morbidity and mortality: Patient phenotypes
por: Bacharaki, Dimitra, et al.
Publicado: (2023)

The Supporting Role of Combined and Sequential Extracorporeal Blood Purification Therapies in COVID-19 Patients in Intensive Care Unit
por: Nalesso, Federico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4i95e49r7g8m27dkru3lr9mgn3